MNI BRIEF: China Passenger Car Sales Up In November Y/Y

MNI China Daily Summary: Monday, December 9

MNI BRIEF: China To Strengthen Policy Easing In 2025: Poliburo

MNI BRIEF: Mexico Inflation Down To 4.55% In November

MNI BRIEF: China Nov CPI Slows To 5-Month Low Of 0.2% Y/Y

MNI: PBOC Sets Yuan Parity Higher At 7.1870 Mon; -1.39% Y/Y

MNI:US OCT WHOLESALE INV 0.2%; SALES -0.1%

EZ/UK Bond Supply Calendar: Austria, UK Auction on Tuesday

MNI JAPAN Q3 GDP REV +0.3% Q/Q; PRELIM +0.2%; MEDIAN +0.2%

MNI EXCLUSIVE: EU-Mercosur Deal Close, But Likely Short-Lived - Officials

AUSTRALIA: 2025 Election Outcome Looking More Uncertain According To Newspoll

© 1982-2024 MNI. All rights reserved.
Terms | Privacy
Log Out
Free Trial

Study-Jabs Reduce Hospital Trips ~94%, Comes As PM Issues Lockdown Roadmap

UK

Scott Beasley at Sky News tweets: "New study from Scotland shows vaccines massively reduce the risk of hospitalisation. By the 4th week after first dose- the risk of hospitalisation is reduced by: Pfizer 85%, AstraZeneca 94%. This is real world data in a study by scientists from the University of Edinburgh, University of Strathclyde and Public Health Scotland. Dataset is entire Scotland population of 5.4m people"

  • The good news on vaccine effectiveness in reducing the risk of hospitalisation comes as UK PM Boris Johnson is due to announce a roadmap to ending lockdown restrictions in England this afternoon in the House of Commons.
  • Widely expected that the unwinding will be very gradual, with several weeks between each of the four stages of removing restrictions. Johnson came in for significant criticism in 2020 for the perception he had removed restrictions too early and too quickly to the detriment of public health. As such he is taking the opposite approach this time and ignoring the more lockdown-sceptic members of his own Conservative party, instead siding with more cautious scientific advice.
Homepagemarkets-real-timePolitical RiskPolitical Risk BulletBulletMarketsFixed Income BulletsForeign Exchange Bullets

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.